• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

lensgen

FDA grants IDE nod to LensGen’s presbyopia-correcting intraocular lens

November 29, 2021 By Sean Whooley

Intraocular lens developer LensGen announced today that it received FDA investigational device exemption (IDE) for its Juvene lens. Irvine, California-based LensGen designed the Juvene intraocular lens (IOL) for patients with cataracts, with the IDE set to initiate a pivotal study for the device. The company developed Juvene IOL t0 permanently restore clear and continuous vision at […]

Filed Under: Clinical Trials, Featured, Food & Drug Administration (FDA), Implants, News Well, Optical/Ophthalmic, Regulatory/Compliance Tagged With: lensgen

LensGen closes $10 million in bridge financing

August 20, 2020 By Sean Whooley

Intraocular lens developer LensGen announced today that it closed the addition of $10 million in a $20 million bridge financing. HOYA Group’s corporate investment arm led the financing, which is part of a larger Series B round planned for early 2021 that is earmarked for funding the company through the approval of a pivotal FDA study […]

Filed Under: Business/Financial News, Funding Roundup, Optical/Ophthalmic Tagged With: lensgen, Personnel Moves

New eye health companies gain funders’ focus

October 17, 2018 By Nancy Crotti

Startups pioneering less-invasive technologies to treat common eye diseases are changing the outlook for both patients and the industry. A new study by CB Insights revealed that investors have been pouring money into smaller companies in 2017 and 2018, with some FDA approvals to begin marketing their technologies and treatments. These firms are eyeing conditions […]

Filed Under: Featured, Funding Roundup, Optical/Ophthalmic, Vision Tagged With: AcuFocus Inc., Alphabet (Google), azura, CB Insights, Ivantis, lensgen, rxsight, tearfilminnovations

LensGen updates on Juvene IOL, adds $15m to Series A

July 17, 2018 By Fink Densford

Intraocular lens developer LensGen said today it hit clinical performance milestones that triggered the release of $11 million that was part of its Series A financing round, and added that lead investor Hoya opted to invest an additional $4.4 million. The Irvine, Calif.-based company also said it is expanding from its current office location into a 14,000 […]

Filed Under: Business/Financial News, Optical/Ophthalmic Tagged With: lensgen

LensGen raises $7.3m

May 16, 2017 By Fink Densford

Intraocular lens developer LensGen raised $7.3 million in a new round of equity funding, according to an SEC filing posted this week. The Irvine, Calif.-based company develops the Juvene accommodating intraocular lens. The Juvene lens is designed to potentially permanently restore clear and continuous vision at all distances for patients with cataracts and presbyopia, LensGen […]

Filed Under: Business/Financial News, Optical/Ophthalmic Tagged With: lensgen

LensGen raises $21m in Series A

May 2, 2017 By Fink Densford

Ophthalmic device developer LensGen said today it closed a $21 million Series A financing round to support its Juvene accommodating intraocular lens. The financing round was led by the corporate venture investment arm of Hoya Group and was joined by Relativity Healthcare Partners, the Irvine, Calif.-based company said. “As one of the leading global intraocular […]

Filed Under: Business/Financial News, Optical/Ophthalmic Tagged With: Hoya Corp., lensgen

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy